Cargando…

Subependymal giant cell astrocytoma -like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type 1-association

Neurofibromatosis type 1 is a familial genetic syndrome associated with a predisposition to develop peripheral and central nervous system neoplasms. We have previously reported on a subset of gliomas developing in these patients with morphologic features resembling subependymal giant cell astrocytom...

Descripción completa

Detalles Bibliográficos
Autores principales: Palsgrove, Doreen N., Brosnan-Cashman, Jacqueline A., Giannini, Caterina, Raghunathan, Aditya, Jentoft, Mark, Bettegowda, Chetan, Gokden, Murat, Lin, Doris, Yuan, Ming, Lin, Ming-Tseh, Heaphy, Christopher M., Rodriguez, Fausto J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269209/
https://www.ncbi.nlm.nih.gov/pubmed/29973652
http://dx.doi.org/10.1038/s41379-018-0103-x
_version_ 1783376450983821312
author Palsgrove, Doreen N.
Brosnan-Cashman, Jacqueline A.
Giannini, Caterina
Raghunathan, Aditya
Jentoft, Mark
Bettegowda, Chetan
Gokden, Murat
Lin, Doris
Yuan, Ming
Lin, Ming-Tseh
Heaphy, Christopher M.
Rodriguez, Fausto J.
author_facet Palsgrove, Doreen N.
Brosnan-Cashman, Jacqueline A.
Giannini, Caterina
Raghunathan, Aditya
Jentoft, Mark
Bettegowda, Chetan
Gokden, Murat
Lin, Doris
Yuan, Ming
Lin, Ming-Tseh
Heaphy, Christopher M.
Rodriguez, Fausto J.
author_sort Palsgrove, Doreen N.
collection PubMed
description Neurofibromatosis type 1 is a familial genetic syndrome associated with a predisposition to develop peripheral and central nervous system neoplasms. We have previously reported on a subset of gliomas developing in these patients with morphologic features resembling subependymal giant cell astrocytoma, but the molecular features of these tumors remain undefined. A total of 14 tumors were studied and all available slides were reviewed. Immunohistochemical stains and telomere-specific FISH were performed on all cases. In addition, next generation sequencing was performed on 11 cases using a platform targeting 644 cancer-related genes. The average age at diagnosis was 28 years (range: 4–60, 9F/5M). All tumors involved the supratentorial compartment. Tumors were predominantly low grade (n=12), with 2 high grade tumors, and displayed consistent expression of glial markers. Next generation sequencing demonstrated inactivating NF1 mutations in 10 (of 11) cases. Concurrent TSC2 and RPTOR mutations were present in two cases (1 sporadic and 1 neurofibromatosis type 1-associated). Interestingly, alternative lengthening of telomeres was present in 4 (of 14) (29%) cases. However, an ATRX mutation associated with aberrant nuclear ATRX expression was identified in only 1 (of 4) cases with alternative lenghtening of telomeres. Mutations in the DNA helicase RECQL4 (n=2) and components of the Fanconi anemia complementation group (FANCD2, FANCF, FANCG) (n=1) were identified in two alternative lenghtening of telomeres -positive/ATRX intact cases. Other variants involved genes related to NOTCH signaling, DNA maintenance/repair pathways, and epigenetic modulators. There were no mutations identified in DAXX, PTEN, PIK3C genes, TP53, H3F3A, HIST1H3B or in canonical hotspots of IDH1, IDH2, or BRAF. A subset of subependymal giant cell astrocytoma-like astrocytomas are alternative lenghtening of telomeres -positive and occur in the absence of ATRX alterations, thereby suggesting mutations in other DNA repair/maintenance genes may also facilitate alternative lenghtening of telomeres. These findings suggest that subependymal giant cell astrocytoma -like astrocytoma represents a biologically distinct group that merits further investigation.
format Online
Article
Text
id pubmed-6269209
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-62692092019-01-04 Subependymal giant cell astrocytoma -like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type 1-association Palsgrove, Doreen N. Brosnan-Cashman, Jacqueline A. Giannini, Caterina Raghunathan, Aditya Jentoft, Mark Bettegowda, Chetan Gokden, Murat Lin, Doris Yuan, Ming Lin, Ming-Tseh Heaphy, Christopher M. Rodriguez, Fausto J. Mod Pathol Article Neurofibromatosis type 1 is a familial genetic syndrome associated with a predisposition to develop peripheral and central nervous system neoplasms. We have previously reported on a subset of gliomas developing in these patients with morphologic features resembling subependymal giant cell astrocytoma, but the molecular features of these tumors remain undefined. A total of 14 tumors were studied and all available slides were reviewed. Immunohistochemical stains and telomere-specific FISH were performed on all cases. In addition, next generation sequencing was performed on 11 cases using a platform targeting 644 cancer-related genes. The average age at diagnosis was 28 years (range: 4–60, 9F/5M). All tumors involved the supratentorial compartment. Tumors were predominantly low grade (n=12), with 2 high grade tumors, and displayed consistent expression of glial markers. Next generation sequencing demonstrated inactivating NF1 mutations in 10 (of 11) cases. Concurrent TSC2 and RPTOR mutations were present in two cases (1 sporadic and 1 neurofibromatosis type 1-associated). Interestingly, alternative lengthening of telomeres was present in 4 (of 14) (29%) cases. However, an ATRX mutation associated with aberrant nuclear ATRX expression was identified in only 1 (of 4) cases with alternative lenghtening of telomeres. Mutations in the DNA helicase RECQL4 (n=2) and components of the Fanconi anemia complementation group (FANCD2, FANCF, FANCG) (n=1) were identified in two alternative lenghtening of telomeres -positive/ATRX intact cases. Other variants involved genes related to NOTCH signaling, DNA maintenance/repair pathways, and epigenetic modulators. There were no mutations identified in DAXX, PTEN, PIK3C genes, TP53, H3F3A, HIST1H3B or in canonical hotspots of IDH1, IDH2, or BRAF. A subset of subependymal giant cell astrocytoma-like astrocytomas are alternative lenghtening of telomeres -positive and occur in the absence of ATRX alterations, thereby suggesting mutations in other DNA repair/maintenance genes may also facilitate alternative lenghtening of telomeres. These findings suggest that subependymal giant cell astrocytoma -like astrocytoma represents a biologically distinct group that merits further investigation. 2018-07-04 2018-12 /pmc/articles/PMC6269209/ /pubmed/29973652 http://dx.doi.org/10.1038/s41379-018-0103-x Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Palsgrove, Doreen N.
Brosnan-Cashman, Jacqueline A.
Giannini, Caterina
Raghunathan, Aditya
Jentoft, Mark
Bettegowda, Chetan
Gokden, Murat
Lin, Doris
Yuan, Ming
Lin, Ming-Tseh
Heaphy, Christopher M.
Rodriguez, Fausto J.
Subependymal giant cell astrocytoma -like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type 1-association
title Subependymal giant cell astrocytoma -like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type 1-association
title_full Subependymal giant cell astrocytoma -like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type 1-association
title_fullStr Subependymal giant cell astrocytoma -like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type 1-association
title_full_unstemmed Subependymal giant cell astrocytoma -like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type 1-association
title_short Subependymal giant cell astrocytoma -like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type 1-association
title_sort subependymal giant cell astrocytoma -like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type 1-association
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269209/
https://www.ncbi.nlm.nih.gov/pubmed/29973652
http://dx.doi.org/10.1038/s41379-018-0103-x
work_keys_str_mv AT palsgrovedoreenn subependymalgiantcellastrocytomalikeastrocytomaaneoplasmwithadistinctphenotypeandfrequentneurofibromatosistype1association
AT brosnancashmanjacquelinea subependymalgiantcellastrocytomalikeastrocytomaaneoplasmwithadistinctphenotypeandfrequentneurofibromatosistype1association
AT gianninicaterina subependymalgiantcellastrocytomalikeastrocytomaaneoplasmwithadistinctphenotypeandfrequentneurofibromatosistype1association
AT raghunathanaditya subependymalgiantcellastrocytomalikeastrocytomaaneoplasmwithadistinctphenotypeandfrequentneurofibromatosistype1association
AT jentoftmark subependymalgiantcellastrocytomalikeastrocytomaaneoplasmwithadistinctphenotypeandfrequentneurofibromatosistype1association
AT bettegowdachetan subependymalgiantcellastrocytomalikeastrocytomaaneoplasmwithadistinctphenotypeandfrequentneurofibromatosistype1association
AT gokdenmurat subependymalgiantcellastrocytomalikeastrocytomaaneoplasmwithadistinctphenotypeandfrequentneurofibromatosistype1association
AT lindoris subependymalgiantcellastrocytomalikeastrocytomaaneoplasmwithadistinctphenotypeandfrequentneurofibromatosistype1association
AT yuanming subependymalgiantcellastrocytomalikeastrocytomaaneoplasmwithadistinctphenotypeandfrequentneurofibromatosistype1association
AT linmingtseh subependymalgiantcellastrocytomalikeastrocytomaaneoplasmwithadistinctphenotypeandfrequentneurofibromatosistype1association
AT heaphychristopherm subependymalgiantcellastrocytomalikeastrocytomaaneoplasmwithadistinctphenotypeandfrequentneurofibromatosistype1association
AT rodriguezfaustoj subependymalgiantcellastrocytomalikeastrocytomaaneoplasmwithadistinctphenotypeandfrequentneurofibromatosistype1association